Sera Prognostics has named Ilia Ichetovkin vice president of lab operations where he will head development and deployment of the company's CLIA lab services and the commercial launch of its proteomic test to predict preterm birth risk.
Ichetovkin formerly was head of oncology at Vela Diagnostics, director of US lab operations with LabCorp Clinical Trials, and head of clinical diagnostics and biomarker development at Abraxis Bioscience.
Biomarker Strategies has appointed Jack Davis as executive chairman. He will serve as both chairman of the board and as the senior strategic management adviser for the firm.
Davis was a co-founder, president, CEO, chairman, and chief operating officer of Dianon Systems, and he also was division vice president and general manager of Abbott Diagnostics' diagnostic products unit.